The COVAX programme has signed deals for hundreds of millions of doses to vaccinate people in poor and lower-middle income ...

From once-a-week insulin to once-a-month weight loss injections, a new era of convenience is reshaping how doctors treat ...

As 2026 begins, pharmaceutical giant Pfizer is navigating a complex landscape marked by both operational challenges and significant financial developments. The company's latest outlook has ...

For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

JENNY Keepe claims ditching her fake lashes helped save her life – as they hid symptoms of a brain tumour caused by her ...

Tammy Croston, Trish Saunders, and Donna MacDonald were each left with meningiomas - non-cancerous tumours - inside their ...

Sanofi’s TSLP and IL-13 inhibitor has aced a pair of mid-stage studies for respiratory diseases, but missed on a phase 2 ...

Track Brooks Laboratories share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and ...

Learn more about whether Halozyme Therapeutics, Inc. or Relay Therapeutics, Inc. is a better investment based on AAII's A+ ...

A proof-of-concept study supports the safety and efficacy of rezpegaldesleukin vs placebo for treating severe-to-very-severe ...

Novo Nordisk (NVO) faces rising GLP-1 competition from Eli Lilly; see pipeline catalysts, patent risks, and a $29/share fair ...

The SLS did not so much lift from its pad as vault from it, carrying its four-person Artemis II crew—International Space ...